Sanchez-Fdez, Adrian
Sharma, Ashwyn K.
Tiriac, Herve
Sicklick, Jason K.
Funding for this research was provided by:
Sarcoma Foundation of America
Foundation for the National Institutes of Health (R01 CA226803, T32 CA121938 Cancer Therapeutics (CT2) Training Fe)
Food and Drug Administration (R01 FD006334)
Article History
Received: 21 June 2022
Accepted: 27 June 2022
First Online: 13 July 2022
Disclosure
: J.K.S. receives research funding from Amgen Pharmaceuticals and Foundation Medicine, consultant fees from Deciphera, speaker’s fees from Deciphera, Foundation Medicine, La-Hoffman Roche, Merck, MJH Life Sciences, QED Therapeutics, and has stock in Personalis.
Free to read: This content has been made available to all.